DXCM peer analysis
DexCom (DXCM) against its competitors: price, today's move, 1-year return and market value side by side.
DXCM and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| BBNX Beta Bionics | $16.38 | -2.24% | -38.85% | – |
| DRIO DarioHealth | $3.00 | -9.37% | -78.65% | $29.40M |
| GCTK GlucoTrack | $1.39 | -32.20% | -99.28% | – |
| MMED MiniMed | $18.85 | 3.12% | – | $5.14B |
| MMEDV MiniMed | $17.70 | 1.17% | – | – |
| PODD Insulet | $152.41 | 1.82% | -51.14% | $10.38B |
| SENS Senseonics | $9.07 | -4.63% | 25.80% | $502.83M |
| TNDM Tandem Diabetes | $18.92 | -0.99% | 29.68% | $1.33B |
| DXCM DexCom | $84.32 | 2.47% | 23.64% | $30.69B |
- DXCM's peers: BBNX (Beta Bionics), DRIO (DarioHealth), GCTK (GlucoTrack), MMED (MiniMed), MMEDV (MiniMed), PODD (Insulet), SENS (Senseonics), TNDM (Tandem Diabetes).
Updated 2026-11-02 17:14 UTC